Maryland, 13 Sept 2024: The FDA issued a warning that use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, can cause rare but serious liver injury, according to an agency View Details

Related News

• Police arrested a person with huge cache of drugs (30-09-2024)

---

• DCC asks sub-committee to look into procedures related to disposal of unused medicines by general public (30-09-2024)

---

• 4 held for selling Mephentermine injections illegally (30-09-2024)

---

• DCC asks committee revisiting Rule 64 to place report for further discussion (30-09-2024)

---

• Jalandhar Police Commissionerate busts national fake degrees racket; 2 arrested (29-09-2024)

---

• Rajkot Hospital OT sealed as 10 develop complications after cataract surgery (29-09-2024)

---

• India's Pharma Future: Regulatory Reforms and Innovation (29-09-2024)

---

• Why are banned cough syrups being sold: High Court issues notice to CDSCO-DGP (29-09-2024)

---

• Hyderabad Police Arrests Individual for Illegal Possession of Mephentermine Injection Vials (29-09-2024)

---

• 4 illegal medical stores seized, operating without licence (29-09-2024)

---